CJC-1295 DAC - Hilma Biocare

CJC-1295 is a modified GHRH analog that stimulates the release of growth hormone and is widely used in fitness for muscle gain, fat loss, and anti-aging purposes. It was developed by ConjuChem in 2005 and gained attention for its extended half-life of 8-10 days, requiring less frequent administration. While the compound showed potential in clinical trials, the development process was halted following a participant's death in 2006, although the death was later determined to be unrelated to the drug.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CJC-1295 DAC by Hilma Biocare, consult with your doctor or healthcare professional.